LMX 4 with Tegaderm Interactions
There are 79 drugs known to interact with LMX 4 with Tegaderm (lidocaine topical), along with 5 disease interactions. Of the total drug interactions, 2 are major, 70 are moderate, and 7 are minor.
- View all 79 medications that may interact with LMX 4 with Tegaderm
- View LMX 4 with Tegaderm disease interactions (5)
Most frequently checked interactions
View interaction reports for LMX 4 with Tegaderm (lidocaine topical) and the medicines listed below.
- acetaminophen / hydrocodone
- Adriamycin (doxorubicin)
- aspirin
- baclofen
- buspirone
- Centrum Silver (multivitamin with minerals)
- Citracal Slow Release 1200 (calcium / vitamin d)
- Copaxone (glatiramer)
- Coumadin (warfarin)
- Depo Provera (medroxyprogesterone)
- dexamethasone / neomycin / polymyxin b ophthalmic
- Dexilant (dexlansoprazole)
- Diflucan (fluconazole)
- duloxetine
- Entresto (sacubitril / valsartan)
- Fentanyl Transdermal System (fentanyl)
- fluticasone nasal
- gabapentin
- Humulin R (insulin regular)
- Keppra (levetiracetam)
- Klonopin (clonazepam)
- Lipitor (atorvastatin)
- Lyrica (pregabalin)
- Morphine Sulfate IR (morphine)
- Neulasta (pegfilgrastim)
- ocrelizumab
- ondansetron
- oxybutynin
- potassium chloride
- Provigil (modafinil)
LMX 4 with Tegaderm disease interactions
There are 5 disease interactions with LMX 4 with Tegaderm (lidocaine topical) which include:
Report options
QR code containing a link to this page
More about LMX 4 with Tegaderm (lidocaine topical)
- Compare alternatives
- Pricing & coupons
- Latest FDA alerts (8)
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical anesthetics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.